Table 3 Synthetic peptides for screening T cell epitopes

1–20

H-MAA LT R DP Q FQKLQQWYREH-OH

23–42

H-ELNLRRL FD A NK D RFNHFSL-OH

37–56

H-FNHFS LT L NT N HGHILVDYS-OH

51–70

H-ILVDYS KN L VT E DVMRMLVD-OH

71–90

H-LA KS R GV E A A RE R MF N GEKI-OH

96–115

H-RAVL HV A LR N RS N TPILVDG-OH

145–164

H-TGKTI TD V IN I GIGGSDLGP-OH

162–181

H-LGPLMV TE A LK P YSSGGPRV-OH

168–187

H-TEALKP YS S GG P RVWYVSNI-OH

176–195

H-SGGPRV WY V SN I DGTHIAKT-OH

191–210

H-HIAKTL AQ L NP E SSLFIIAS-OH

200–219

H-NP ES S LF I IA S KT F TT Q ETI-OH

225–244

H-AKEWFL Q AA K DP SAVAKHFV-OH

238–257

H-AVAKHF VA L ST N TTKVKEFG-OH

247–266

H-STNTTKV KE F GI D PQNMFEF-OH

280–299

H-IGLSIA LH V GF D NFEQLLSG-OH

313–332

H-EKNAPVL LA L LG I WYINCFG-OH

327–346

H-YI NC F GC E TH A ML P YD Q YLH-OH

386–405

H-NGQHAF YQ L IH Q GTKMIPCD-OH

400–419

H-KMIP CD FL I PV QT Q HPIRKG-OH

420–439

H-LHHKILL AN F LA Q TEALMRG-OH

445–464

H-ARKELQAA GK S PE D LERLLP-OH

484–503

H-PFMLGA LV A MY E HKIFVQGI-OH

533–552

H-AQVTS HD A ST N GL I NFIKQQ-OH

539–558

H-DASTNGL IN F IK Q QREARVQ-OH